Questions linger over Frist stock sale

The investigation into Senate Majority Leader Bill Frist's recent sale of shares in healthcare giant HCA is no more than a political witch hunt, argue some observers. "The case is a non-starter that has political appeal," said Jacob Frenkel of Shulman Rogers, a former SEC prosecutor, in an interview in today's USA Today. But not everybody agrees. The Wall Street Journal reports that others are questioning how blind the blind trust shielding Frist's investments really was and how much the politician actually knew about his investments in the healthcare company.

- see this story from USA Today
- see this story from The Wall Street Journal (sub. req.)